4th Quarter - Report
FOLEY HOAG LLP for AMGEN
Firm
Client
Income
$110,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAREY | — |
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
| DAVID MOHLER | — |
| BARRETT THORNHILL | — |
| LINDSEY TOOHEY | — |
Medicare/Medicaid MMM
Patient Protection and Affordable Care Act - H.R.3590 Medicare coverage and reimbursement Medicaid Drug Rebate Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAREY | — |
| PAUL KIM | — |
| DAVID MOHLER | — |
| BARRETT THORNHILL | — |
| LINDSEY TOOHEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.